The role of the granulocyte colony-stimulating factor receptor (G-CSF-R) in disease

Frontiers in Bioscience

Volumn 12, Issue 2, 2007, Pages 608-618

  Ward, Alister C ^a  

^a DEAKIN UNIVERSITY   (Australia)

Author keywords

Colony stimulating factor; Cytokine; G CSF; Granulocyte; Leukemia; Neutropenia; Receptor; Review

Indexed keywords

EID: 33846921639     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2086     Document Type: Article

References (110)

1. Nicola, N. A.: Hemopoietic cell growth factors and their receptors. Ann Rev Biochem 58, 45-77 (1989)
2. Demetri, G. D., and J. D. Griffin: Granulocyte colony-stimulating factor and its receptor. Blood 78, 2791-2808 (1991)
3. Lieschke, G. J., D. Grail, G. Hodgson, D. Metcalf, E. Stanley, C. Cheers, K. J. Fowler, S. Basu, Y. F. Zhan, and A. R. Dunn: Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor deficiency, and impaired neutrophil mobilization. Blood 84, 1737-1746. (1994)
4. Anderlini, P., D. Przepiorka, R. Champlin, and M. Korbling: Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood 88, 2819-2825 (1996)
5. Avalos, B. R.: Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 88, 761-777 (1996)
6. van de Geijn, G. J., L. H. J. Aarts, S. J. Erkeland, J. M. Prasher, and I. P. Touw: Granulocyte colony-stimulating factor and its receptor in normal hematopoietic cell development and myeloid disease. Rev Physiol Biochem Pharmacol 149, 53-71 (2003)
7. Fukunaga, R., E. Ishizaka Ikeda, Y. Seto, and S. Nagata: Expression cloning of a receptor for murine granulocyte colony-stimulating factor. Cell 61, 341-350 (1990)
8. Liu, F., H. Y. Wu, R. Wesselschmidt, T. Kornaga, and D. C. Link: Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity 5, 491-501 (1996)
9. Hermans, M. H., G. J. van de Geijn, C. Antonissen, J. Gits, D. van Leeuwen, A. C. Ward, and I. P. Touw: Signaling mechanisms coupled to tyrosines in the granulocyte colony-stimulating factor receptor orchestrate G-CSF-induced expansion of myeloid progenitor cells. Blood 101, 2584-2590 (2003)
10. Druhan, L. J., J. Ai, P. Massullo, T. Kindwall-Keller, M. A. Ranalli, and B. R. Avalos: Novel mechanism of G-CSF refractoriness in patients with severe congenital neutropenia. Blood 105, 584-591 (2005)
11. Nicholson, S. E., A. C. Oates, A. G. Harpur, A. Ziemiecki, A. F. Wilks, and J. E. Layton: Tyrosine kinase JAK1 is associated with the granulocyte-colony stimulating factor receptor and both become tyrosine phosphorylated after receptor activation. Proc Natl Acad Sci USA 91, 2985-2988 (1994)
12. Nicholson, S. E., U. Novak, S. F. Ziegler, and J. E. Layton: Distinct regions of the granulocyte colony-stimulating factor receptor are required for tyrosine phosphorylation of the signaling molecules JAK2, Stat3, and p42,p44 MAPK. Blood 86, 3698-3704 (1995)
13. Barge, R. M., J. P. de Koning, K. Pouwels, F. Dong, B. Löwenberg, and I. P. Touw: Tryptophan 650 of human granulocyte colony-stimulating factor (G-CSF) receptor, implicated in the activation of JAK2, is also required for G-CSF-mediated activation of signaling complexes of the p21ras route. Blood 87, 2148-2153 (1996)
14. Tian, S.-S., P. Tapley, C. Sincich, R. B. Stein, J. Rosen, and P. Lamb: Multiple signaling pathways induced by granulocyte colony-stimulating factor involving activation of JAKs, STATS, and/or STAT3 are required for regulation of three distinct classes of immediate early genes. Blood 88, 4435-4444 (1996)
15. Corey, S. J., A. L. Burkhardt, J. B. Bolen, R. L. Geahlen, L. S. Tkatch, and D. J. Tweardy: Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases. Proc Natl Acad Sci USA 91, 4683-4687 (1994)
16. Corey, S. J., P. M. Dombrosky-Ferlan, S. Zuo, E. Krohn, A. D. Donnenberg, P. Zorich, G. Romero, M. Takata, and T. Kurosaki: Requirement of Src kinase Lyn for induction of DNA synthesis by granulocyte colony-stimulating factor. J Biol Chem 273, 3230-3235 (1998)
17. Ward, A. C., J. L. Monkhouse, X. F. Csar, I. P. Touw, and P. A. Bello: The Src-like kinase Hck is activated by granulocyte colony-stimulating factor (G-CSF), and docks to the activated G-CSF receptor. Biochem Biophys Res Comm 251, 117-123 (1998)
18. Zhu, Q. S., L. J. Robinson, V. Roginskaya, and S. J. Corey: G-CSF-induced tyrosine phosphorylation of Gab2 is Lyn kinase dependent and associated with enhanced Akt and differentiative, not proliferative, responses. Blood 103, 3305-3312 (2004)
19. Zhu, Q. S., L. Xia, G. B. Mills, C. A. Lowell, I. P. Touw, and S. J. Corey: G-CSF induced reactive oxygen species involves Lyn-PI 3-kinase-Akt and contributes to myeloid cell growth. Blood E-pub Nov 10, (2005)
20. Tian, S.-S., P. Lamb, H. M. Seidel, R. B. Stein, and J. Rosen: Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor. Blood 84, 1760-1764 (1994)
21. de Koning, J. P., F. Dong, L. Smith, A. M. Schelen, R. M. Barge, D. C. van der Plas, L. H. Hoefsloot, B. Löwenberg, and I. P. Touw: The membrane-distal cytoplasmic region of human granulocyte colony-stimulating factor receptor is required for STAT3 but not STAT1 homodimer formation. Blood 87, 1335-1342 (1996)
22. Shimoda, K., J. Feng, H. Murakami, S. Nagata, D. Watling, N. C. Rogers, G. R. Stark, I. M. Kerr, and J. N. Ihle: Jakl plays an essential role for receptor phosphorylation and Stat activation in response to granulocyte colony-stimulating factor. Blood 90, 597-604 (1997)
23. Ward, A. C., M. H. A. Hermans, L. Smith, Y. M. van Aesch, A. M. Schelen, C. Antonissen, and I. P. Touw: Tyrosine-dependent and independent mechanisms of STAT3 activation by the human granulocyte colony-stimulating factor (G-CSF) receptor are differentially utilized depending on G-CSF concentration. Blood 93, 113-124 (1999)
24. Bashey, A., L. Healy, and C. J. Marshall: Proliferative but not nonproliferative responses to granulocyte-colony stimulating factor are associated with rapid activation of the p21ras/MAP kinase signalling pathway. Blood 83, 949-957 (1994)
25. de Koning, J. P., A. A. Soede-Bobok, A. M. Schelen, L. Smith, D. van Leeuwen, V. Santini, B. M. T. Burgering, J. L. Bos, B. Löwenberg, and I. P. Touw: Proliferation signaling and activation of Shc, p21Ras and Myc via tyrosine 764 of human granulocyte colony-stimulating factor receptor. Blood 91, 1924-1933 (1998)
26. Rausch, O., and C. J. Marshall: Cooperation of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways during granulocyte colony-stimulating factor-induced hemopoietic cell proliferation. J Biol Chem 274, 4096-4105 (1999)
27. Hunter, M. G., and B. R. Avalos: Phosphatidylinositol 3'-kinase and SH2-containing inositol phosphatase (SHIP) are recruited by distinct positive and negative growth-regulatory domains in the granulocyte colony-stimulating factor receptor. J Immunol 160, 4979-4987 (1998)
28. Dong, F., and A. C. Lamer: Activation of Akt kinase by granulocyte colony-stimulating factor (G-CSF): evidence for the role of a tyrosine kinase activity distinct from the Janus kinases. Blood 95, 1656-1662 (2000)
29. Hortner, M., U. Nielsch, L. M. Mayr, J. A. Johnston, P. C. Heinrich, and S. Haan: Suppressor of cytokine signaling-3 is recruited to the activated granulocyte-colony stimulating factor receptor and modulates its signal transduction. J Immunol 169, 1219-1227 (2002)
30. Hunter, M. G., A. Jacob, C. O'Donnell L, A. Agler, L. J. Druhan, K. M. Coggeshall, and B. R. Avalos: Loss of SHIP and CIS recruitment to the granulocyte colony-stimulating factor receptor contribute to hyperproliferative responses in severe congenital neutropenia/acute myelogenous leukemia. J Immunol 173, 5036-5045 (2004)
31. van de Geijn, G. J., J. Gits, L. H. Aarts, C. Heijmans-Antonissen, and I. P. Touw: G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STATS but leave suppression of STAT3 intact. Blood 104, 667-674 (2004)
32. Dong, F., Y. Qiu, T. Yi, I. P. Touw, and A. C. Lamer: The carboxyl terminus of the granulocyte colony-stimulating factor receptor, truncated in patients with severe congenital neutropenia/acute myeloid leukemia, is required for SH2-containing phosphatase-1 suppression of Stat activation. J Immunol 167, 6447-6452 (2001)
33. Zeidler, C., B. Schwinzer, and K. Weite: Congenital neutropenias. Rev Clin Exp Hematol 7, 72-83 (2003)
34. Amato, D., M. H. Freedman, and E. F. Saunders: Granulopoiesis in severe congenital neutropenia. Blood 47, 531-538 (1976)
35. Kawaguchi, Y., M. Kobayashi, A. Tanabe, M. Hara, Y. Nishi, T. Usui, S. Nagai, Y. Nishibayashi, K. Nagao, and K. Yokoro: Granulopoiesis in patients with congenital neutropenia. Am J Hematol 20, 223-234 (1985)
36. Kostmann, R.: Infantile genetic agranulocytosis. Acta Paediatr 45 (Suppl.105), 1-78 (1956)
37. Gillio, A. P., and J. L. Gabrilove: Cytokine treatment of inherited bone marrow failure syndromes. Blood 81, 1669-1674 (1993)
38. Kalra, R., D. Dale, M. Freedman, M. A. Bonilla, M. Weinblatt, A. Ganser, P. Bowman, S. Abish, J. Priest, R. S. Oseas, K. Olson, D. Paderanga, and K. Shannon: Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia. Blood 86, 4579-4586 (1995)
39. Freedman, M. H.: Congenital marrow failure syndromes and malignant hematopoietic transformation. Oncologist 1, 354-360 (1996)
40. Aprikyan, A. A., T. Kutyavin, S. Stein, P. Aprikian, E. Rodger, W. C. Liles, L. A. Boxer, and D. C. Dale: Cellular and molecular abnormalities in severe congenital neutropenia predisposing to leukemia. Exp Hematol 31, 372-381 (2003)
41. Kobayashi, M., C. Yumiba, Y. Kawaguchi, Y. Tanaka, K. Ueda, Y. Komazawa, and K. Okada: Abnormal responses of myeloid progenitor cells to recombinant human colony-stimulating factors in congenital neutropenia. Blood 75, 2143-2149 (1990)
42. Weite, K., C. Zeidler, A. Reiter, W. Muller, E. Odenwald, L. Souza, and H. Riehm: Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood 15, 1056-1063 (1990)
43. Bonilla, M., A. Gillio, M. Ruggeiro, N. Kernan, J. Brochstein, M. Abboud, L. Fumagalli, M. Vincent, J. Gabrilove, K. Weite, L. Souza, and R. O'Reilly: Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. New Eng J Med 320, 1574-1580 (1989)
44. Dale, D. C., M. A. Bonilla, M. W. Davis, A. M. Nakanshi, W. P. Hammond, J. Kurtzberg, W. Wang, A. Jubowski, E. Winton, P. Lalezari, W. Robinson, J. A. Glaspy, S. Emerson, J. Gabrilove, M. Vincent, and L. A. Boxer: A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (Filgrastim) for treatment of severe chronic neutropenia. Blood 81, 2496-2502 (1993)
45. Hartmann, L. C., L. K. Tschetter, T. M. Habermann, L. P. Ebbert, P. S. Johnson, J. A. Mailliard, R. Levitt, V. J. Suman, T. E. Witzig, H. S. Wieand, L. L. Miller, and C. G. Moertel: Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia. N Engl J Med 336, 1776-1780 (1997)
46. Levine, J. E., and L. A. Boxer: Clinical applications of hematopoietic growth factors in pediatric oncology. Curr Opin Hematol 9, 222-227 (2002)
47. Bohlius, J., M. Reiser, G. Schwarzer, and A. Engert: Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma: a systematic review. Br J Haematol 122, 413-423 (2003)
48. Bensinger, W. I., C. H. Weaver, F. R. Appelbaum, S. Rowley, T. Demirer, J. Sanders, R. Storb, and C. D. Buckner: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85, 1655-1658 (1995)
49. Demirer, T., M. Ayli, M. Ozean, N. Gunel, R. Haznedar, M. Dagli, T. Fen, Y. Gene, S. Dincer, O. Arslan, G. Gurman, S. Demirer, G. Ozet, A. Uysal, N. Konuk, O. Ihlan, H. Koc, and H. Akan: Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF. Br J Haematol 116, 468-474 (2002)
50. Dong, F., R. K. Brynes, N. Tidow, K. Weite, B. Löwenberg, and I. P. Touw: Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med 333, 487-493 (1995)
51. Dong, F., D. C. Dale, M. A. Bonilla, M. Freedman, A. Fasth, H. J. Neijens, J. Palmblad, G. L. Briars, G. Carlsson, A. J. Veerman, K. Welte, B. Löwenberg, and I. P. Touw: Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Leukemia 11, 120-125 (1997)
52. Dong, F., C. van Buitenen, K. Pouwels, L. H. Hoefsloot, B. Löwenberg, and I. P. Touw: Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation. Mol Cell Biol 13, 7774-7781 (1993)
53. Dong, F., L. H. Hoefsloot, A. M. Schelen, C. A. Breeders, Y. Meijer, A. J. Veerman, I. P. Touw, and B. Löwenberg: Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia. Proc Natl Acad Sci USA 91, 4480-4484 (1994)
54. Ancliff, P. J., R. E. Gale, R. Liesner, I. Hann, and D. C. Linch: Long-term follow-up of granulocyte colony-stimulating factor receptor mutations in patients with severe congenital neutropenia: implications for leukaemogenesis and therapy. Br J Haematol 120, 685-690 (2003)
55. Bernard, T., R. E. Gale, J. P. M. Evans, and D. C. Linch: Mutations of the granulocyte-colony stimulating factor receptor in patients with severe congenital neutropenia are not required for transformation to acute myeloid leukaemia and may be a bystander phenomenon. Br J Hematol 101, 141-149 (1998)
56. Tidow, N., C. Pilz, B. Teichmann, A. Muller-Brechlin, M. Germeshausen, B. Kasper, P. Rauprich, K.-W. Sykora, and K. Welte: Clinical relevance of point mutations in the cytoplasmic domain of the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Blood 89, 2369-2375 (1997)
57. Welte, K., and I. P. Touw: G-CSF receptor mutations in patients with severe chronic neutropenia: a step in leukemogenesis. Blood 90, 433a (1997)
58. Germeshausen, M., M. Ballmaier, H. Schulze, K. Welte, T. Flohr, K. Beisje, I. Storm-Mathisen, and T. G. Abrahamsen: Granulocyte colony-stimulating factor receptor mutations in a patient with acute lymphoblastic leukemia secondary to severe congenital neutropenia. Blood 97, 829-830 (2001)
59. Cassinat, B., C. Bellanne-Chantelot, A. Notz-Carrere, M. L. Menot, C. Vaury, M. Micheau, B. Bader-Meunier, Y. Perel, T. Leblanc, J. Donadieu, and C. Chomienne: Screening for G-CSF receptor mutations in patients with secondary myeloid or lymphoid transformation of severe congenital neutorpenia. A report form the French neutropenia register. Leukemia 18, 1553-1555 (2004)
60. Freedman, M. H., and B. P. Alter: Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias. Semin Hematol 39, 128-133 (2002)
61. Donadieu, J., T. Leblanc, B. Bader Meunier, M. Barkaoui, O. Fenneteau, Y. Bertrand, M. Maier-Redelsperger, M. Micheau, J. L. Stephan, N. Phillipe, P. Bordigoni, A. Babin-Boilletot, P. Bensaid, A. M. Manel, E. Vilmer, I. Thuret, S. Blanche, E. Gluckman, A. Fischer, F. Mechinaud, B. Joly, T. Lamy, O. Hermine, B. Cassinat, C. Bellanne-Chantelot, and C. Chomienne: Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica 90, 45-53 (2005)
62. Germeshausen, M., H. Schulze, C. Kratz, L. Wilkens, R. Repp, K. Shannon, K. Weite, and M. Ballmaier: An acquired G-CSF receptor mutation results in increased proliferation of CMML cells from a patient with severe congenital neutropenia. Leukemia 19, 611-617 (2005)
63. Jeha, S., K. W. Chan, A. G. Aprikyan, W. K. Hoots, S. Culbert, H. Zietz, D. C. Dale, and M. Albitar: Spontaneous remission of granulocyte colony-stimulating factor-associated leukemia in a child with severe congenital neutropenia. Blood 96, 3647-3649 (2000)
64. Tschan, C. A., C. Pilz, C. Zeidler, K. Welte, and M. Germeshausen: Time course of increasing numbers of mutations in the granulocyte colony-stimulating factor receptor gene in a patient with congenital neutropenia who developed leukemia. Blood 97, 1882-1884 (2001)
65. Hermans, M. H. A., A. C. Ward, C. Antonissen, A. Karis, B. Lowenberg, and I. P. Touw: Perturbed granulopoiesis in mice with a targeted mutation in the granulocyte colony-stimulating factor receptor gene associated with severe chronic neutropenia. Blood 92, 32-39 (1998)
66. Mitsui, T., S. Watanabe, Y. Taniguchi, S. Hanada, Y. Ebihara, T. Sato, T. Heike, M. Mitsuyama, T. Nakahata, and K. Tsuji: Impaired neutrophil maturation in truncated murine G-CSF receptor transgenic mice. Blood 101, 2990-2995 (2003)
67. Hermans, M. H. A., C. Antonissen, A. C. Ward, A. E. M. Mayen, R. E. Ploemacher, and I. P. Touw: Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia/acute myeloid leukemia-derived mutation in the G-CSF receptor gene. J Exp Med 189, 683-692 (1999)
68. McLemore, M. L., J. Poursine-Laurent, and D. C. Link: Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia. J Clin Invest 102, 483-492 (1998)
69. Li, F. Q., and M. Horwitz: Characterization of mutant neutrophil elastase in severe congenital neutropenia. J Biol Chem 276, 14230-14241 (2001)
70. Bellanne-Chantelot, C., S. Clauin, T. Leblanc, B. Cassinat, F. Rodrigues-Lima, S. Beaufils, C. Vaury, M. Barkaoui, O. Fenneteau, M. Maier-Redelsperger, C. Chomienne, and J. Donadieu: Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register. Blood 103, 4119-4125 (2004)
71. Person, R. E., F. Q. Li, Z. Duan, K. F. Benson, J. Wechsler, H. A. Papadaki, G. Eliopoulos, C. Kaufman, S. J. Bertolone, B. Nakamoto, T. Papayannopoulou, H. L. Grimes, and M. Horwitz: Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet 34, 308-312 (2003)
72. Devriendt, K., A. S. Kim, G. Mathijs, S. G. Frints, M. Schwartz, J. J. Van Den Oord, G. E. Verhoef, M. A. Boogaerts, J. P. Fryns, D. You, M. K. Rosen, and P. Vandenberghe: Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet 27, 313-317 (2001)
73. Nakajima, K., Y. Yamanaka, K. Nakae, H. Kojima, M. Ichiba, N. Kiuchi, T. Kitaoka, T. Fukada, M. Hibi, and T. Hirano: A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J 15, 3651-3658 (1996)
74. Shimozaki, K., K. Nakajima, T. Hirano, and S. Nagata: Involvement of STAT3 in the granulocyte colony-stimulating factor-induced differentiation of myeloid cells. J Biol Chem 272, 25184-25189 (1997)
75. Ward, A. C., L. Smith, J. P. de Koning, Y. van Aesch, and I. P. Touw: Multiple signals mediate proliferation, differentiation and survival from the granulocyte colony-stimulating factor receptor in myeloid 32D cells. J Biol Chem 274, 14956-14962 (1999)
76. de Koning, J. P., A. A. Soede-Bobok, A. C. Ward, A. M. Schelen, C. Antonissen, D. van Leeuwen, B. Lowenberg, and I. P. Touw: STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1). Oncogene 19, 3290-3298 (2000)
77. Chakraborty, A., K. F. Dyer, M. Cascio, T. A. Mietzner, and D. J. Tweardy: Identification of a novel Stat3 recruitment and activation motif within the granulocyte colony-stimulating factor receptor. Blood 93, 15-24 (1999)
78. Ward, A. C., Y. M. van Aesch, A. M. Schelen, and I. P. Touw: Defective internalization and sustained activation of truncated granulocyte colony-stimulating factor receptor found in severe congenital neutropenia/acute myeloid leukemia. Blood 93, 447-458 (1999)
79. Lee, C. K., R. Raz, R. Gimeno, R. Gertner, B. Wistinghausen, K. Takeshita, R. A. DePinho, and D. E. Levy: STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation. Immunity 17, 63-72 (2002)
80. Hunter, M. G., and B. R. Avalos: Deletion of a critical internalization domain in the G-CSFR in acute myelogenous leukemia preceded by severe congenital neutropenia. Blood 93, 440-446 (1999)
81. Teglund, S., C. McKay, E. Schuetz, J. M. van Deursen, D. Stravopodis, D. Wang, M. Brown, S. Bodner, G. Grosveld, and J. N. Ihle: Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93, 841-850 (1998)
82. Ilaria, R. L., Jr., R. G. Hawley, and R. A. Van Etten: Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation. Blood 93, 4154-4166 (1999)
83. Dong, F., X. Liu, J. P. de Koning, I. P. Touw, L. Henninghausen, A. Larner, and P. M. Grimley: Stimulation of Stat5 by granulocyte colony-stimulating factor (G-CSF) is modulated by two distinct cytoplasmic regions of the G-CSF receptor. J Immunol 161, 6503-6509 (1998)
84. Hunter, M. G., and B. R. Avalos: Granulocyte colony-stimulating factor receptor mutations in severe congenital neutropenia transforming to acute myeloid leukemia confer resistance to apoptosis and enhance cell survival. Blood 95, 2132-2137 (2000)
85. Moriggl, R., V. Sexl, L. Kenner, C. Duntsch, K. Stangl, S. Gingras, A. Hoffmeyer, A. Bauer, R. Piekorz, D. Wang, K. D. Bunting, E. F. Wagner, K. Sonneck, P. Valent, J. N. Ihle, and H. Beug: Stat5 tetramer formation is associated with leukemogenesis. Cancer Cell 1, 87-99 (2005)
86. Lewis, R. S., S. E. M. Stephenson, and A. C. Ward: Constitutive activation of zebrafish stat5 expands hematopoietic populations in vivo. Exp Hematol, in press (2006)
87. McLemore, M. L., S. Grewal, F. Liu, A. Archambault, J. Poursine-Laurent, J. Haug, and D. C. Link: STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation. Immunity 14, 193-204. (2001)
88. Ward, A. C., Y. M. van Aesch, J. Gits, A. M. Schelen, J. P. de Koning, D. van Leeuwen, M. H. Freedman, and I. P. Touw: Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment. J Exp Med 190, 497-507 (1999)
89. Sinha, S., Q. S. Zhu, G. Romero, and S. J. Corey: Deletional mutation of the external domain of the human granulocyte colony-stimulating factor receptor in a patient with severe chronic neutropenia refractory to granulocyte colony-stimulating factor. J Pediatr Hematol Oncol 25, 791-796 (2003)
90. Papadaki, H. A., T. Kosteas, C. Gemetzi, A. Damianaki, N. P. Anagnou, and G. D. Eliopoulos: Acute myeloid/NK precursor cell leukemia with trisomy 4 and a novel point mutation in the extracellular domain of the G-CSF receptor in a patient with chronic idiopathic neutropenia. Ann Hematol 83, 345-348 (2004)
91. Forbes, L. V., R. E. Gale, A. Pizzey, K. Pouwels, A. Nathwani, and D. C. Linch: An activating mutation in the transmembrane domain of the granulocyte colony-stimulating factor receptor in patients with acute myeloid leukemia. Oncogene 21, 5981-5989 (2002)
92. d'Andrea, R. J., and T. J. Gonda: A model for assembly and activation of the GM-CSF, IL-3 and IL-5 receptors: insights from activated mutants of the common beta subunit. Exp Hematol 28, 231-243 (2000)
93. Awaya, N., H. Uchida, Y. Miyakawa, K. Kinjo, H. Matsushita, H. Nakajima, Y. Ikeda, and M. Kizaki: Novel variant isoform of G-CSF receptor involved in induction of proliferation of FDCP-2 cells: relevance to the pathogenesis of myelodysplastic syndrome. J Cell Physiol 191, 327-335 (2002)
94. Wolfler, A., S. J. Erkeland, C. Bodner, M. Valkhof, W. Renner, C. Leitner, W. Olipitz, M. Pfeilstocker, C. Tinchon, W. Emberger, W. Linkesch, I. P. Touw, and H. Sill: A functional single-nucleotide polymorphism of the G-CSF receptor gene predisposes individuals to high-risk myelodysplastic syndrome. Blood 105, 3731-3736 (2005)
95. Dong, F., M. van Paassen, C. van Buitenen, L. H. Hoefsloot, B. Löwenberg, and I. P. Touw: A point mutation in the granulocyte colony-stimulating factor receptor (G-CSF-R) gene in a case of acute myeloid leukemia results in the overexpression of a novel G-CSF-R isoform. Blood 85, 902-911 (1995)
96. de Lau, W. B., J. Hurenkamp, P. Berendes, I. P. Touw, H. C. Clevers, and M. A. van Dijk: The gene encoding the granulocyte colony-stimulating factor receptor is a target for deregulation in pre-B ALL by the t(1;19)-specific oncoprotein E2A-Pbx1. Oncogene 17, 503-510 (1998)
97. Shimizu, K., I. Kitabayashi, N. Kamada, T. Abe, N. Maseki, K. Suzukawa, and M. Ohki: AML1-MTG8 leukemic protein induces the expression of granulocyte colony-stimulating factor (G-CSF) receptor through the up-regulation of CCAAT/enhancer binding protein epsilon. Blood 96, 288-296 (2000)
98. Inukai, T., K. Sugita, K. Mitsui, K. Iijima, K. Goi, T. Tezuka, S. Kojika, K. Kagami, T. Mori, A. Kinoshita, T. Suzuki, T. Okazaki-Koyama, and S. Nakazawa: Participation of granulocyte colony-stimulating factor in the growth regulation of leukemia cells from Philadelphia chromosome-positive acute leukemia and blast crisis of chronic myeloid leukemia. Leukemia 14, 1386-1395 (2000)
99. Katayama, N., K. Kita, K. Kawakami, H. Mitani, T. Sugawara, S. Mizuno, A. Yonezawa, K. Nishii, H. Miwa, H. Wada, N. Minami, and H. Shiku: Granulocyte colony-stimulating factor and its receptor in acute promyelocytic leukemia. Am J Hematol 58, 31-35 (1998)
100. White, S. M., E. D. Ball, W. C. Ehmann, A. S. Rao, and D. J. Tweardy: Increased expression of the differentiation-defective granulocyte colony-stimulating factor receptor mRNA isoform in acute myelogenous leukemia. Leukemia 12, 899-906 (1998)
101. Ninci, E. B., T. Brandstetter, I. Meinhold-Heerlein, H. Bettendorf, D. Sellin, and T. Bauknecht: G-CSF receptor expression in ovarian cancer. Int J Gynecol Cancer 10, 19-26 (2000)
102. Savarese, T. M., K. Mitchell, C. McQuain, C. L. Campbell, R. Guardiani, J. Wuu, C. Ollari, F. Reale, B. E. Nelson, A. Chen, and P. J. Quesenberry: Coexpression of granulocyte colony stimulating factor and its receptor in primary ovarian carcinomas. Cancer Lett 162, 105-115 (2001)
103. Chakraborty, A., S. M. White, and S. P. Lerner: Granulocyte colony-stimulating factor receptor signals for betal-integrin expression and adhesion in bladder cancer. Urology 63, 177-183 (2004)
104. Sunaga, H., S. Fujieda, H. Tsuzuki, K. Asamoto, M. Fukuda, and H. Saito: Expression of granulocyte colony-stimulating factor receptor and platelet-derived endothelial cell growth factor in oral and oropharyngeal precancerous lesions. Anticancer Res 21, 2901-2906 (2001)
105. Hirai, K., M. Kumakiri, S. Fujieda, H. Sunaga, L. M. Lao, Y. Imamura, K. Ueda, and M. Fukuda: Expression of granulocyte colony-stimulating factor and its receptor in epithelial skin tumors. J Dermatol Sci 25, 179-188 (2001)
106. Tsuzuki, H., S. Fujieda, H. Sunaga, I. Noda, and H. Saito: Expression of granulocyte colony-stimulating factor receptor correlates with prognosis in oral and mesopharyngeal carcinoma. Cancer Res 58, 794-800 (1998)
107. Sugimoto, C., S. Fujieda, H. Sunaga, I. Noda, N. Tanaka, Y. Kimura, H. Saito, and S. Matsukawa: Granulocyte colony-stimulating factor (G-CSF)-mediated signaling regulates type IV collagenase activity in head and neck cancer cells. Int J Cancer 93, 42-46 (2001)
108. Horwitz, M., K. F. Benson, R. E. Person, A. G. Aprikyan, and D. C. Dale: Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet 23, 433-436 (1999)
109. Hunter, M. G., L. J. Druhan, P. R. Massullo, and B. R. Avalos: Proteolytic cleavage of granulocyte colony-stimulating factor and its receptor by neutrophil elastase induces growth inhibition and decreased cell surface expression of the granulocyte colony-stimulating factor receptor. Am J Hematol 14, 149-155 (2003)
110. El Ouriaghli, F., H. Fujiwara, J. J. Melenhorst, G. Sconocchia, N. Hensel, and A. J. Barrett: Neutrophil elastase enzymatically antagonizes the in vitro action of G-CSF: implications for the regulation of granulopoiesis. Blood 101, 1752-1758 (2003)